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Abstract
Population imaging studies generate data for developing and implementing personalised health strategies to
prevent, or more effectively treat disease. Large prospective epidemiological studies acquire imaging for pre-
symptomatic populations. These studies enable the early discovery of alterations due to impending disease,
and enable early identification of individuals at risk. Such studies pose new challenges requiring automatic
image analysis. To date, few large-scale population-level cardiac imaging studies have been conducted.
One such study stands out for its sheer size, careful implementation, and availability of top quality expert
annotation; the UK Biobank (UKB). The resulting massive imaging datasets (targeting ca. 100,000 subjects)
has put published approaches for cardiac image quantification to the test. In this paper, we present and
evaluate a cardiac magnetic resonance (CMR) image analysis pipeline that properly scales up and can provide
a fully automatic analysis of the UKB CMR study. Without manual user interactions, our pipeline performs
end-to-end image analytics from multi-view cine CMR images all the way to anatomical and functional
bi-ventricular quantification. All this, while maintaining relevant quality controls of the CMR input images,
and resulting image segmentations. To the best of our knowledge, this is the first published attempt to fully
automate the extraction of global and regional reference ranges of all key functional cardiovascular indexes,
from both left and right cardiac ventricles, for a population of 20,000 subjects imaged at 50 time frames
per subject, for a total of one million CMR volumes. In addition, our pipeline provides 3D anatomical
bi-ventricular models of the heart. These models enable the extraction of detailed information of the
morphodynamics of the two ventricles for subsequent association to genetic, omics, lifestyle habits, exposure
information, and other information provided in population imaging studies. We validated our proposed
CMR analytics pipeline against manual expert readings on a reference cohort of 4,620 subjects with contour
delineations and corresponding clinical indexes. Our results show broad significant agreement between the
manually obtained reference indexes, and those automatically computed via our framework. 80.67% of
subjects were processed with mean contour distance of less than 1 pixel, and 17.50% with mean contour
distance between 1 and 2 pixels. Finally, we compare our pipeline with a recently published approach
reporting on UKB data, and based on deep learning. Our comparison shows similar performance in terms
of segmentation accuracy with respect to human experts.
Keywords: UK Biobank, Cardiac MR, Quality Assessment, Statistical Shape Models, Population
Imaging, Fully Automatic Analysis, Cardiac Functional Indexes, Cardiac Morphological Analysis
1. Introduction
Cardiovascular disease (CVD) is the most preva-
lent cause of death worldwide (Roth et al., 2017).
Diagnosis of CVDs is often made at late symp-
tomatic stages, leading to late interventions at high
cost and with substantially decreased efficacy of
treatment. Early quantitative assessment of car-
diac function that allows for proper preventive
care, and early cardiovascular treatment is therefore
paramount. To support such an approach, large-
scale population-based imaging studies of CVDs are
increasingly possible given the advent of standard-
ised robust non-invasive imaging methods, and the
infrastructure for big data analysis (Fang et al.,
2016). These advancements open further oppor-
tunities for gaining new information about the de-
velopment and progression of CVDs across various
population groups (Lardo et al., 2004; Medrano-
Gracia et al., 2015).
The analysis and interpretation of cardiac struc-
tural and functional indexes in large-scale popula-
tion imaging data can help identify patterns and
trends across population groups, and accordingly,
reveal insights into key risk factors before CVDs
fully develop. Established to investigate the deter-
minants of a disease, the UK Biobank (UKB) is
one of the world’s largest prospective population
studies (Petersen et al., 2015). The UKB data con-
tain extensive baseline questionnaire data, biolog-
ical samples, physical measurements, and cardio-
vascular magnetic resonance (CMR) images to es-
tablish cardiovascular imaging-derived phenotypes
(Petersen et al., 2013). CMR is an important com-
ponent of multi-organ multi-modality imaging vis-
its for patients in multiple dedicated UKB imag-
ing centres that will acquire and store imaging data
from 100,000 participants by 2022.
In terms of population sample size, experimen-
tal setup, and quality control, the most reliable
reference ranges for cardiovascular structure and
function found in the literature are those reported
by Petersen et al. (2017), in which CMR scans
were manually delineated and analysed by a team
of eight expert observers using the commercially
available cvi42 post-processing software (Version
5.1.1, Circle Cardiovascular Imaging Inc., Calgary,
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Canada). The expert team comprised of biomedical
engineers, radiologists, image analysts and cardiol-
ogists, evaluated the quality of every image, and
performed delineations. In cases where the image
quality was doubtful, the team jointly decided upon
exclusion. These reference values (delineations and
volumes) comprise 4,620 subjects and are used in
our present study to validate our proposed frame-
work and workflow.
In this paper, we present a novel fully auto-
matic 3D image parsing workflow with embedded
quality control, and evaluate its performance on
the UKB. We validate our results by comparing
with published manual analysis and one state-of-
the-art method. Our proposed workflow is capable
of segmenting the cardiac ventricles and generating
global and regional clinical reference ranges compa-
rable to those obtained by human raters and flag-
ship methods.
In addition to comparing against manual mea-
surements, we also compare our performance
against one state-of-the-art method, i.e., the re-
cent work by Bai et al. (2018) in which the authors
propose a 2D convolutional neural network (CNN)-
based segmentation method for analysis of the UKB
CMR images. Though in our study, we processed a
much greater number of subjects (20, 000), we per-
formed experiments with smaller subsets of data
to make direct comparisons with the existing lit-
erature. We are interested in showing the advan-
tages of true 3D shape analysis, over 2D CNN-
based techniques, which, due to their per-slice dis-
joint nature, and absence of global constraints, lack
the ability to infer or extrapolate noisy or miss-
ing data. We believe true 3D analysis is valuable,
or even essential, for further structural analysis of
regional myocardial function. Our 3D generative-
based approach ensures global coherence of the car-
diac anatomy and naturally lends itself to further
analysis in which full 3D anatomy is necessary; for
example, in mechanical and flow simulations.
Finally, since the power of population studies lies
in the ability to provide normative reference values
for sub-populations, enabling more patient-specific
evaluation, we provide reference ranges for cardiac
clinical indexes in sub-populations based on age-
group and gender.
The main contributions of this paper are, first,
reproducing the cardiac functional index ranges de-
rived from expert delineations reported in (Petersen
et al., 2015), and providing additional 3D-based
ranges of local variation. Second, showcasing a
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fully scalable framework, capable of processing ar-
bitrarily large population imaging studies, in a com-
pletely automatic manner. In this paper we demon-
strate this by processing 20,000 subjects from the
UKB study, each comprised of 50 time frames for
a total of one million image volumes, starting from
raw input data, through data cleaning, quality as-
sessment, 3D segmentation, volume computation,
and statistical analysis.
The remainder of this paper is organised as fol-
lows. In Section 2, we present our strategy for data
processing scalability, and detail each of the mod-
ules comprising our image quantification pipeline.
In Section 3, we present a thorough evaluation of
our pipeline, both from technical, and clinical per-
spectives, including detailed statistics on global and
local cardiovascular indexes. Finally, in Section 4,
we present final remarks.
2. Methodology
Illustrated in Figure 1, our CMR image parsing
pipeline consists of the following four phases: (1)
pre-processing; (2) quality analysis; (3) segmenta-
tion; and (4) quantification. In the subsections that
follow, we describe the methods used within each
step and our design choices. In the next subsec-
tion, we highlight the framework used to integrate
this pipeline and streamline its execution both in
terms of scalability and distributability.
2.1. Workflow Integration and Execution
To scale both data access and computation, we
propose a modular pipeline and developed an in-
house cloud-based image analytics framework called
MULTI-X 1 (de Vila et al., 2018). MULTI-X en-
ables both distributed access to data storage and
distributed execution of image analysis pipelines
on the cloud. Further, MULTI-X facilitates se-
cure access and execution, component integration
and interoperability (e.g., across different program-
ming languages, frameworks, operating systems,
and hardware), workflow execution, monitoring,
and execution report generation. MULTI-X can
also serve as middleware between storage and com-
puting cloud providers (e.g., Amazon Web Services,
GoogleCloud, and Microsoft Azure), workflow man-
agers (e.g., Taverna and Nipype), data sources (e.g.,
UKB servers) and analytics tools providers. In our
1https://multi-x.org
implementation, we selected Nipype (Gorgolewski
et al., 2011) as the workflow manager. Further, we
selected Amazon Web Services2 to provide high-
performance storage and computing in a cloud-
based environment. More specifically, an Amazon
Simple Storage Service (S3) provided unstructured
data storage, Amazon Redshift provided data ware-
housing for petabyte-scale data analysis, and Ama-
zon’s Elastic Cloud Computing (EC2) enabled on-
demand adaptive cloud computing.
2.2. Data Pre-processing
Before describing our data pre-processing phase,
first note that we accessed the UKB data under Ac-
cess Applications #2964 and #11350. UKB project
has been approved by National Research Ethics
Service North West (11/NW/0382) and all partic-
ipants gave written consent to participate and to
publish as part of the UKB recruitment process.
The full CMR protocol in the UKB has been de-
scribed in detail elsewhere (Petersen et al., 2015).
Researchers can apply to use the UKB resource for
health related research that is in the public inter-
est3.
Once obtained, data were transferred to a secure
AWS S3 server accessible from an experimental de-
ployment of MULTI-X, the aforementioned cloud-
based infrastructure for our pipeline-oriented image
analytics. A production deployment of MULTI-X
installed within the UKB is presently under way
and will provide a corporate data analytics frame-
work. When new data are available, this production
implementation of MULTI-X will provide continued
image analytics for the volunteers whose CMR data
collection is an ongoing task. The UKB Imaging
Study undertakes detailed MRI scans of key vital
organs of the human body using specialised imag-
ing protocols that extend CMR. For each volunteer,
relevant CMR subseries are extracted from the full
imaging study, viz. short axis (SAX) and long axis
(LAX) two-, three- and four-chamber CMR images.
2.3. Quality Analysis
At least two quality analysis modules are required
to ensure the reliability of the extracted cardiac in-
dexes. The first module assesses the quality of the
input images, whereas the second module assesses
the quality of the quantification outputs, i.e., the
2https://aws.amazon.com
3https://www.ukbiobank.ac.uk/register-apply
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Figure 1: Schematic showing our fully automatic image parsing framework for large-scale analysis of cardiac ventricles. CMR
images first go through the pre-processing phase, then flow into both the quality analysis and segmentation phases, which in
turn communicate with one another, finally producing output that the last phase of quantification handles.
generated 3D segmentations. Each of these is de-
scribed in the subsections that follow.
2.3.1. Image Quality Assessment
Despite careful and strict imaging protocols, a
significant portion of the data collected in popula-
tion imaging studies, inevitably falls outside stan-
dard operating procedures. To ensure the quality
and correctness of the collected data, thereby opti-
mising the accuracy of the generated segmentation
results, an image quality assessment (IQA) module
detects suboptimal images whose inclusion in sub-
sequent analysis would impair aggregated statistics
over the entire cohort.
More specifically, because the absence of basal
and/or apical slices in SAX views forms the most
frequently occurring problem affecting the accu-
racy of volumetric measurements and correspond-
ing clinical indexes (Klinke et al., 2013), our IQA
module detects situations in which these slices are
missing. In our design, SAX slices are processed in-
dependently through two CNN classifiers that de-
termine the presence/absence of basal and apical
slices, respectively. Details of the algorithm we used
to achieve this effect can be found in the work pub-
lished by Zhang et al. (2016).
2.3.2. Segmentation Quality Assessment
Regarding segmentation quality assessment
(SQA), large anatomical variations found across
subject populations (Valindria et al., 2017) and
other forms of poor image quality beyond full
ventricular coverage can cause image segmentation
failures. We therefore propose an automated self-
diagnosis mechanism for detecting unsatisfactory
segmentation results. Flagged images can then
be either re-processed with revised parameters
or discarded from subsequent statistical analyses.
We incorporate a segmentation quality assessment
approach presented by Alba` et al. (2018). The
SQA module uses a random forest classifier trained
to distinguish between successful and unsuccessful
segmentations based on intensity features around
the blood pool and myocardial boundaries.
2.4. Segmentation
For the segmentation phase of our workflow, we
use SAX and LAX CMR images to estimate the
approximate position and orientation of the car-
diac ventricles. We then initialise the segmentation
of the cardiac structure following a Sparse Active
Shape Model (SPASM) approach (Van Assen et al.,
2006). More specifically, SPASM is used to segment
the full cardiac cycle and retrospectively determine
the end-diastolic (ED) and end-systolic (ES) phases
of the cycle based on the frames showing maximum
and minimum volumes, respectively. Before run-
ning our segmentation approach across all subjects,
we applied grid search optimisation to a subset of
50 subjects to identify the parameters having the
greatest impact on segmentation performance; we
describe this further in Section 2.4.3.
2.4.1. Model Initialisation
To automatically initialise the model, we use the
method proposed by Alba` et al. (2018) with a fur-
4
ther step to improve bi-ventricular model initialisa-
tion. First, the location of the LV is determined via
a rough estimate of the intersection of slices from
the SAX and LAX views. Next, a random forest
regressor trained with two complementary feature
descriptors (i.e., the Histogram of Oriented Gra-
dients and Gabor Filters) predicts the landmark
positions for the LV. We extend this to take into
account image features corresponding to the RV,
thereby improving the initial estimate for the loca-
tion of the bi-ventricular heart. We then use these
landmarks to estimate pose parameters that place a
mean shape model near the heart. Finally, we use
these pose parameters to initialise the first image
volume in the set of images for the cardiac cycle
(i.e., 50 cardiac phases). Subsequent time frames
are automatically initialised via the shape model
fitted to the immediately preceding cardiac phase.
2.4.2. Image Model Fitting
In this subsection, we consider how we fit the
image model. First, the cardiac LV and RV seg-
mentations are obtained via the aforementioned
SPASM segmentation method that improves on
the Active Shape Models (ASM) approach (Cootes
et al., 1995) by addressing the sparsity found in
imaging modalities such as CMR in which image
information is sparsely distributed across the en-
tirety of the image. The main components of the
SPASM method are the Point Distribution Model
(PDM), the Intensity Appearance Model (IAM)
and a model matching algorithm.
The PDM encodes the mean and variance of the
endocardial and epicardial shapes of the LV and
the endocardial shape of the RV. The PDM is con-
structed during training using principal component
analysis (PCA) on a set of generalised Procrustes-
aligned shapes that preserve a 98% variance.
To illustrate this, assume a training set of M
shapes, each described by N points in R3, i.e.,
xij = (x
i
j ,y
i
j , z
i
j) with i = 1, ...,M and j = 1, ..., N .
Further, let si = (x
i
1,y
i
1, z
i
1, ...,x
i
N ,y
i
N , z
i
N )
T be
the i-th vector representing the shape of the i-th en-
docardial and epicardial surfaces of LV and the en-
docardial surface of RV. Finally, let S = [s1, ..., sM ]
be the set of all training shapes in matrix form.
Here, all nuisance pose parameters (e.g., transla-
tion, rotation and scaling) have been removed from
S using generalised Procrustes analysis. The shape
class mean and covariance of S is then as follows:
s¯ =
1
M
M∑
i=1
si (1)
C =
1
M − 1
M∑
i=1
(si − s¯)(si − s¯)T (2)
The shape covariance is represented in a low-
dimensional space or PCA of the shape. That
produces l eigenvectors Φ = [ϕ1ϕ2...ϕl], and cor-
responding eigenvalues Λ = diag(λ1, λ2, ..., λl) of
the covariance matrix computed via Singular Value
Decomposition. Hence, assuming the shape class
follows a multi-dimensional Gaussian probability
distribution, any shape in the shape class can be
approximated from the following linear generative
model:
s ≈ s¯ + Φb (3)
where b are shape parameters restricted to |bi| ≤
β
√
λi; we typically set β = 3 to capture 99.7% of
shape variability. The shape parameters of s can
then be estimated as follows:
b = ΦTl (s− s¯). (4)
Here, the entries of b are the projection coefficients
of mean-centred shapes (s − s¯) along the columns
of Φ.
Next, for each landmark in s, we build an IAM
based on intensity information across all corre-
sponding landmarks in all training shapes si. More
specifically, IAMs capture the local intensity distri-
bution along cardiac boundaries. We proceed by
sampling one-dimensional intensity profiles normal
to the myocardial boundaries. Each profile has a
length of m = 15 pixels. For the i-th landmark, we
estimate mean intensity profile g¯i and correspond-
ing image intensity covariance Sgi .
During image segmentation, the intersections of
the current shape model instance with all image
planes collectively define a stack of two-dimensional
contours in R3. The algorithm proceeds by search-
ing for the intensity profile location along the nor-
mal to the contours and over the imaging planes for
each landmark. To derive the best-matching posi-
tion or candidate point yi for each landmark, we
minimise the Mahalanobis distance between a pro-
file sampled at candidate position yi, gi(yi) and
corresponding model {g¯i,Sgi} as follows:
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yoi = arg min
yi
((g(yi)− g¯i)T S−1gi (g(yi)− g¯i)). (5)
Given the sparse nature of CMR images, it is
not uncommon during fitting to have mesh triangles
that do not intersect with any image slices in the
stack. In this situation, the points that comprise
these triangles would not be updated or displaced
by the IAM, instead, these points would be pas-
sively updated by fitting of the PDM. A mechanism
that propagates displacements from points that are
image-driven to nearby points that are not, is there-
fore necessary. SPASM implements a displacement
propagation strategy modelled as a Gaussian kernel
centred at any given image-driven point q by prop-
agating its effect to a neighbouring point p based
on Gaussian kernel
w(p, q) = exp{−‖p− q‖
2
2σ2
} (6)
where σ is the width of the kernel. Having a non-
zero Gaussian kernel is not an indispensable feature
of the algorithm as non-image driven points would
be indirectly updated by the PDM, nevertheless,
this feature adds smoothness to the evolution of
the surface mesh, and speeds up convergence of the
algorithm.
2.4.3. Parameter Optimisation
SPASM segmentation is affected by four key pa-
rameters. We ran an exhaustive grid optimisation
scheme to determine the best combination of pa-
rameters. The individual parameters and corre-
sponding ranges that we tested were as follows:
1. Freedom of the PDM measured in standard de-
viations from the mean i.e. β = 2, 2.5, 3.
2. Length of the image sampling profile gi used
during image feature search, measured in pixels
i.e. l = 5, 10, 15 pixels.
3. Standard deviation of the Gaussian kernel for
the point displacement propagation feature i.e.
σ = 5, 7, 9 mm.
4. Image orientations to use, i.e. using only SAX
images or using both SAX and LAX during
segmentation i.e. v = SAX,ALL.
Table 1 shows each of the 54 (i.e. 3 × 3 × 3 ×
2 = 54) unique parameter combinations we used
with our algorithm to segment 50 randomly selected
subjects that had already been manually delineated
by clinicians. Next, we computed the segmentation
accuracy using three key metrics: Dice Similarity
Coefficient (DSC), Mean Contour Distance (MCD)
and Hausdorff Distance (HD). These metrics are
defined on Equations 7, 8 and 9, respectively, in
Section 3.1.
Table 1: The list of 54 distinct sets of segmentation param-
eters used in our segmentation algorithm parameter optimi-
sation. As noted in the text, test 4 was the best choice.
Test β l σ v Test β l σ v
01 2 5 5 SAX 28 2.5 10 7 ALL
02 2 5 5 ALL 29 2.5 10 9 SAX
03 2 5 7 SAX 30 2.5 10 9 ALL
04 2 5 7 ALL 31 2.5 15 5 SAX
05 2 5 9 SAX 32 2.5 15 5 ALL
06 2 5 9 ALL 33 2.5 15 7 SAX
07 2 10 5 SAX 34 2.5 15 7 ALL
08 2 10 5 ALL 35 2.5 15 9 SAX
09 2 10 7 SAX 36 2.5 15 9 ALL
10 2 10 7 ALL 37 3 5 5 SAX
11 2 10 9 SAX 38 3 5 5 ALL
12 2 10 9 ALL 39 3 5 7 SAX
13 2 15 5 SAX 40 3 5 7 ALL
14 2 15 5 ALL 41 3 5 9 SAX
15 2 15 7 SAX 42 3 5 9 ALL
16 2 15 7 ALL 43 3 10 5 SAX
17 2 15 9 SAX 44 3 10 5 ALL
18 2 15 9 ALL 45 3 10 7 SAX
19 2.5 5 5 SAX 46 3 10 7 ALL
20 2.5 5 5 ALL 47 3 10 9 SAX
21 2.5 5 7 SAX 48 3 10 9 ALL
22 2.5 5 7 ALL 49 3 15 5 SAX
23 2.5 5 9 SAX 50 3 15 5 ALL
24 2.5 5 9 ALL 51 3 15 7 SAX
25 2.5 10 5 SAX 52 3 15 7 ALL
26 2.5 10 5 ALL 53 3 15 9 SAX
27 2.5 10 7 SAX 54 3 15 9 ALL
Figure 2 shows three boxplots summarising the
results based on the three metrics, for each of the
54 test parameter sets. The x-axis on each of the
boxplots (DSC, MCD, HD) shows the test number,
and the tests are sorted from best to worst per-
formance. On Figure 2 it can been seen that the
best performing parameter test set is test number
4, which appears at the left-most end of each of the
plots. Specifically, the best parameter values were:
β = 2, l = 5, σ = 7 and v = ALL. We used this
parameter set for segmentation thereon.
2.5. Quantification
For the final phase of our workflow, we com-
puted a thorough set of functional parameters based
on blood-pool and myocardial volumes. To re-
produce the reference ranges reported by Petersen
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Figure 2: Results of our segmentation algorithm parameter optimisation. Here, the set of parameters that jointly yielded the
best results for the DSC, MCD and HD metrics was test 4.
et al. (2017), our quantification module performs
volume computations using Simpson’s method of
integration, whereby a cardiac 3D volume can be
approximated by summing the areas within 2D seg-
mentation contours, and multiplying by the inter-
slice spacing. Because the output of our segmenta-
tion are 3D triangular meshes, before using Simp-
son’s rule, we had to extract contours correspond-
ing to the intersection between our segmentation
and CMR image slices. The 3D model we use for
segmentation is comprised of two structures; the
LV and the RV. The LV is a closed water-tight
mesh comprising both endocardial and epicardial
walls. The RV is an open mesh representing only
the RV endocardium. The RV has two openings,
the atrio-ventricular valve opening, and pulmonary
valve opening. The LV and RV sit adjacent to each
other but are not connected.
We computed both global and regional morpho-
logical and functional indexes. Global indices in-
clude chamber volumes, stroke volume, ejection
fraction and myocardial mass. Regional or local in-
dices include myocardial wall thickness, wall motion
and thickening computed for every segment in the
AHA-17 cardiac subdivision scheme (Heller et al.,
2002).
The global assessment of cardiac function is
based on the following volumetric measurements
(Frangi et al., 2001):
• End-Diastolic Volume (EDV) (ml): the volume
of blood in the LV or RV before contraction.
This is the highest ventricular volume of blood
in the cardiac cycle.
• End-Systolic Volume (ESV) (ml): the volume
of blood in the LV or RV at the end of contrac-
tion. This is the lowest ventricular volume of
blood in the cardiac cycle.
• Stroke Volume (SV) (ml): the volume of blood
pumped from the ventricle per beat obtained
by subtracting the ESV from the EDV for a
given ventricle. This term can be applied to
either of the two ventricles.
• Ejection Fraction (EF) (%): the fraction of
blood ejected from a ventricle of the heart with
each heartbeat. This measure shows the pump-
ing efficiency of the heart and is calculated by
dividing the SV by the EDV. Note that the left
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ventricular EF (LVEF) is a measure of the ef-
ficiency of pumping blood into the body’s sys-
temic circulation, whereas the right ventricu-
lar EF (RVEF) is a measure of the efficiency
of pumping blood into pulmonary circulation
(i.e. the lungs).
• Left Ventricular Mass (LVM) (g): to compute
LVM, we assume that the volume of the my-
ocardium is equal to the total volume con-
tained within the epicardial borders of the ven-
tricle minus the chamber volume. Given these
standard assumptions, LVM is calculated by
multiplying the volume by the density of the
muscle tissue (1.05 g/cm3).
The regional assessment of cardiac function is
based on the following indexes obtained from the
LV myocardial shapes and computed locally based
on the AHA 17-segment model. In contrast to
the global indexes, where comparison with manual
analysis was desired, and therefore 2D techniques
were required (Simpson’s rule), this segmental anal-
ysis was performed directly on 3D shapes, and using
3D techniques. Every measurement was computed
on a per-point basis, and then averaged across all
subjects, for every AHA-17 segment.
• LV Wall Thickness (mm): the distance be-
tween the endocardial and epicardial walls of
the myocardium at ED and ES. Wall thickness
may be used to quantify regional dysfunction,
e.g. in myocardial ischaemia or after myocar-
dial infarction. Myocardial thickness was mea-
sured as the average point-to-surface distance
for every AHA-17 segment across the popula-
tion.
• LV Wall Thickening (mm): the difference in
the wall thickness measurement between ED
and ES. Our models do not include papillary
muscle or trabecular tissue, nor do the manual
contours we compare our measurements with.
• LV Wall Motion (mm): the root-mean-squared
distance between the location of mesh points at
ED and ES averaged per AHA-17 region of the
myocardium.
In the next section, we present and compare all
the aforementioned global and regional clinical in-
dexes obtained through manual and automatic seg-
mentation.
3. Experiments and Results
We evaluated the performance of our proposed
automated workflow by using common metrics for
segmentation accuracy assessment (i.e. the afore-
mentioned DSC, MCD and HD measures), compar-
ing these measures against the ground-truth values
obtained through manual delineation by clinicians
and using clinical cardiac bi-ventricular functional
indexes derived from manual and automated seg-
mentations such as EDV, ESV and LVM.
We also compared our results with those reported
by Bai et al. (2018). In Table 2, we present the
data we used for training, testing and evaluating
our workflow. Of the 4,870 available subjects in
the UKB with manual segmentations, 250 random
subjects were selected for PDM training, with 170
image volumes from a previous study by Tobon-
Gomez et al. (2012) used for IAM training. The
remaining 4,620 subjects in the UKB with man-
ual delineations were used as test datasets to eval-
uate the performance of our proposed automatic
approach, labelled AS in the table. To compare our
results with those of Bai et al. (2018), denoted B
in the table, we used the same training and test-
ing datasets, reporting the results as AL in the ta-
ble. As an additional assessment, we conducted a
quantitative evaluation of human performance by
measuring the inter-observer variability among the
segmentations performed manually by three differ-
ent clinical experts. Here, we randomly selected 50
subjects; each subject was independently analysed
by three expert observers labelled O1, O2 and O3.
We compare segmentation results on the same set of
subjects to show automated versus human perfor-
mance, as well as the performance of our workflow
on a larger dataset.
Input images and output segmentation contours
were automatically quality controlled to ensure that
input image volumes had full coverage of the heart
i.e. included both basal and apical slices and to
verify the quality of the output segmentations. Be-
cause our aim here is to properly evaluate segmen-
tation accuracy, all segmentation results (including
outliers) were included in the statistics in Section
3.1. In contrast, results presented in Section 3.2 are
based only on good quality images and segmenta-
tions, i.e., excluding those deemed suboptimal by
SQA and/or not providing full coverage by IQA.
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Table 2: Specific datasets used for training and testing the methods proposed and presented in this paper.
Label Method Training/Tuning Data Test Data
B Method by Bai et al. (2018) 4,275 subjects from UKB
1) 600 subjects from UKB
2) 50 subjects from UKB
AS Our method (Small training dataset)
PDM: 250 subjects from UKB
IAM: 170 subjects from
Tobon-Gomez et al. (2012)
1) 4,620 subjects from UKB
2) 600 subjects from UKB
3) 50 subjects from UKB
AL Our method (Large training dataset)
PDM: 4,275 subjects from UKB
IAM: 4,275 subjects from UKB
600 subjects from UKB
O1-O3 Human readers Manual contours 50 subjects from UKB (three expert readers)
3.1. Segmentation Accuracy
To quantify segmentation accuracy, we applied
the three aforementioned metrics, each of which is
detailed below. First, the DSC evaluates the over-
lap between automated segmentation A and man-
ual segmentation M; we define DSC as follows:
DSC =
2|A ∩M|
|A|+ |M| (7)
DSC is between 0 and 1, with a higher DSC indicat-
ing a better match between the two segmentations.
The MCD and HD measures evaluate the mean and
maximum distance, respectively, between segmen-
tation contours ∂A and ∂M. These measures are
defined as follows:
MCD =
1
2|∂A|
∑
p∈∂A
d(p, ∂M)+
1
2|∂M|
∑
q∈∂M
d(q, ∂A)
(8)
HD = max(max
p∈∂A
d(p, ∂M), max
q∈∂M
d(q, ∂A)) (9)
where d(p, ∂) denotes the minimal distance from
point p to contour ∂. The lower the distance metric,
the better the agreement.
Table 3 presents DSC, MCD and HD measures
that compare automated and manual segmentation
results; evaluations were performed on test sets con-
sisting of 50, 600 and 4,620 subjects which have
not been used to train the PDM or IAM. Here, the
group of 50 subjects is the same set used to eval-
uate inter-observer variability, whereas the set of
600 subjects is the same set used as a test set in
Bai et al. (2018) in which a deep learning approach
was used for segmentation. The large set of 4,620
subjects is all UKB cases with manual delineations
that have not been used for shape and appearance
model training.
In Table 3, the mean and standard deviations
of DSC for the LVendo, LVmyo and RVendo with
n = 4, 620 were 0.93 ± 0.05, 0.87 ± 0.05, and
0.87 ± 0.07, respectively, indicating excellent agree-
ment between manual delineations and automated
segmentations. We also observe that DSC measures
for the LVmyo and RVendo cases were less than that
of the LVendo case. One possible reason DSC values
for the LVmyo are lower is that its annular shape has
a larger perimeter (i.e. endo and epicardial edge)
causing equal overlap shifts to produce greater error
compared to the LVendo and RVendo.
Further, the RV is a more challenging structure to
segment compared to the LV. This is due to the sub-
pixel thickness of the RV myocardium, the larger
presence of trabeculations in the cavity with sig-
nal intensities similar to that of the myocardium,
the more complex crescent shape of the RV, which,
varies from base to apex, and considerable variabil-
ity in shape and intensity of the chamber across
subjects, notably in pathological cases.
Next, we observe that the MCD is 1.18 ± 0.41
mm for the LVendo, 1.23 ± 0.50 mm for the LVmyo,
and 1.80 ± 0.69 mm for the RVendo, all of which
are smaller than the in-plane pixel spacing range of
1.8 to 2.3 mm. The HD measures were 3.44 ± 1.08
mm, 3.98 ± 1.49 mm and 7.84 ± 3.19 mm for the
LVendo, LVmyo and RVendo, respectively. Although
HD measures are larger than the in-plane pixel
spacing, they are still within acceptable range com-
pared to inter-observer variability. For instance, the
first three columns of Table 3 show inter-observer
variability, where the variability between observers
O1 and O2 for the HD metric is 7.56 ± 5.51 mm.
When comparing our method (i.e. AS and AL)
with B, there was a notable difference in perfor-
mance between the relatively small training set (i.e.
AS) and the same training set as that of B (i.e.
AL). In Table 3, we note a slight improvement of
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Table 3: Segmentation results based on the different test sets (see Table 2) used in Bai et al. (2018), and Petersen et al. (2017)
(n=50, 600, and 4,620). The metrics used are DSC, MCD and HD. We compare manual with automatic methods, and error
between human observers. M represents the manual ground-truth provided by Petersen et al. (2017). LVendo represents LV
endocardium, LVmyo represents LV myocardium, and RVendo represents RV endocardium. Table values are shown as mean ±
standard deviation.
(a) DSC
O1 vs O2 O2 vs O3 O3 vs O1 B vs M AS vs M B vs M AS vs M AL vs M AS vs M
Test-set (n=50) (n=50) (n=50) (n=50) (n=50) (n=600) (n=600) (n=600) (n=4620)
LVendo 0.94 ± 0.04 0.92 ± 0.04 0.93 ± 0.04 0.94 ± 0.04 0.93 ± 0.03 0.94 ± 0.04 0.93 ± 0.05 0.94 ± 0.04 0.93 ± 0.05
LVmyo 0.88 ± 0.02 0.87 ± 0.03 0.88 ± 0.02 0.87 ± 0.03 0.88 ± 0.03 0.88 ± 0.03 0.87 ± 0.04 0.87 ± 0.03 0.87 ± 0.05
RVendo 0.87 ± 0.06 0.88 ± 0.05 0.89 ± 0.05 0.86 ± 0.07 0.87 ± 0.06 0.90 ± 0.05 0.88 ± 0.06 0.89 ± 0.05 0.87 ± 0.07
(b) MCD (mm)
O1 vs O2 O2 vs O3 O3 vs O1 B vs M AS vs M B vs M AS vs M AL vs M AS vs M
Test-set (n=50) (n=50) (n=50) (n=50) (n=50) (n=600) (n=600) (n=600) (n=4620)
LVendo 1.00 ± 0.25 1.30 ± 0.37 1.21 ± 0.48 1.08 ± 0.30 1.28 ± 0.39 1.04 ± 0.35 1.21 ± 0.36 1.06 ± 0.35 1.18 ± 0.41
LVmyo 1.16 ± 0.34 1.19 ± 0.25 1.21 ± 0.36 1.18 ± 0.31 1.20 ± 0.34 1.14 ± 0.40 1.23 ± 0.48 1.13 ± 0.35 1.23 ± 0.50
RVendo 2.00 ± 0.79 1.78 ± 0.45 1.87 ± 0.74 2.20 ± 0.92 1.79 ± 0.80 1.78 ± 0.70 1.80 ± 0.80 1.74 ± 0.61 1.80 ± 0.69
(c) HD (mm)
O1 vs O2 O2 vs O3 O3 vs O1 B vs M AS vs M B vs M AS vs M AL vs M AS vs M
Test-set (n=50) (n=50) (n=50) (n=50) (n=50) (n=600) (n=600) (n=600) (n=4620)
LVendo 2.84 ± 0.70 3.31 ± 0.90 3.25 ± 0.96 3.46 ± 1.05 3.21 ± 0.97 3.16 ± 0.98 3.29 ± 1.04 3.15 ± 0.96 3.44 ± 1.08
LVmyo 3.70 ± 1.16 3.82 ± 1.07 3.76 ± 1.21 4.06 ± 1.16 3.91 ± 1.20 3.92 ± 1.37 3.97 ± 1.43 3.90 ± 1.29 3.98 ± 1.49
RVendo 7.56 ± 5.51 7.35 ± 2.19 7.14 ± 2.20 9.02 ± 3.54 7.41 ± 4.11 7.25 ± 2.70 7.54 ± 3.20 7.21 ± 2.62 7.84 ± 3.19
the mean and standard deviation values, particu-
larly for MCD measures. Nevertheless, improve-
ments become more apparent in Figure 3, where the
number of outlying subjects was drastically reduced
for AL as compared to both B and AS. Although
the overall mean and standard deviation values re-
mained slightly better for B, we observe in Figure 3
that AL was generally more robust as it reduced the
number and deviation of outlying results.
Also from Figure 3, we note that the performance
of AS largely agrees with the ground-truth and is
comparable to the results of B. We also investigated
the segmentation accuracy of the LV myocardium
in detail based on the AHA 17-segment model of
Heller et al. (2002) to report on local segmentation
accuracy in terms of DSC, MCD and HD measures
between manual segmentation and automatic ap-
proaches, i.e. B and AS on the test set of size 600.
We report local segmentation accuracy in Table 4,
which shows that B and AS consistently performed
better with mid-ventricular and apical slices, re-
spectively; however, for base slices, the performance
of B and AS varies per region.
Note that when comparing the performance of AS
versus B (n = 600) in Table 3, B yielded slightly
better global results than AS, but in breaking down
the results into specific cardiac regions (basal, mid
and apical), as presented in Table 4 we observe that
our method, AS, consistently outperformed B for all
metrics in the apical region (AHA segments 13-17).
A possible reason for this is an inability of the CNN
method to capture small features in the image, and
the inherent ability of PDMs to infer missing or
noisy image data.
To provide a visual sense of the quality of
our segmentations, we defined three categories
based on the mean contour distance from the gold
standard, i.e., excellent (MCD < 1 pixel), good
(1 pixel < MCD < 2 pixels) and bad (MCD > 2 pix-
els). We present examples of these categories in
Figure 4, thereby showing that automated segmen-
tation agrees well with manual segmentation both
at ED and ES; further, such agreement occurs at
different slice locations (i.e. apical, mid and basal
regions). Finally, Table 5 shows the prevalence of
the different categories of segmentation quality for
the different approaches presented in this paper.
3.2. Estimation of Cardiac Function Indexes
In this subsection, we present our work in eval-
uating the accuracy of cardiac function indexes
derived from automated segmentation using gold
standard reference ranges derived from manual seg-
mentations. Further, we report on analysis of all
available CMR images from the UKB, which to date
is 20K subjects. More specifically, we calculate the
10
Table 4: Regional segmentation accuracy of LV myocardium based on the AHA 17-segment model covering 600 subjects. Values
indicate mean ± standard deviation. Bold indicates the cases in which our algorithm (i.e. AS) outperformed algorithm B.
DSC MCD HD
B vs M AS vs M B vs M AS vs M B vs M AS vs M
Basal
1 0.82 ± 0.03 0.84 ± 0.02 0.97 ± 0.7 0.95 ± 0.37 3.52 ± 1.00 2.29 ± 1.71
2 0.86 ± 0.03 0.82 ± 0.03 1.10 ± 0.48 1.28 ± 0.36 2.86 ± 1.11 3.30 ± 0.92
3 0.85 ± 0.04 0.83 ± 0.03 1.01 ± 0.36 1.10 ± 0.39 3.86 ± 1.04 2.31 ± 0.95
4 0.85 ± 0.01 0.83 ± 0.02 0.82 ± 0.36 0.93 ± 0.34 3.59 ± 1.49 2.86 ± 1.23
5 0.83 ± 0.03 0.85 ± 0.01 1.10 ± 0.34 1.16 ± 0.44 2.94 ± 1.41 3.12 ± 1.16
6 0.86 ± 0.01 0.85 ± 0.03 1.07 ± 0.45 1.01 ± 0.42 3.45 ± 1.28 3.28 ± 1.02
Mid
7 0.90 ± 0.02 0.86 ± 0.03 0.88 ± 0.37 0.98 ± 0.43 2.06 ± 1.31 3.68 ± 1.24
8 0.91 ± 0.03 0.86 ± 0.02 1.14 ± 0.42 1.20 ± 0.45 3.42 ± 1.26 3.72 ± 1.33
9 0.89 ± 0.03 0.87 ± 0.02 1.04 ± 0.31 1.08 ± 0.38 2.63 ± 1.30 3.80 ± 0.93
10 0.88 ± 0.02 0.87 ± 0.02 1.34 ± 0.37 1.49 ± 0.36 2.76 ± 1.22 3.88 ± 1.09
11 0.90 ± 0.03 0.88 ± 0.02 1.16 ± 0.43 1.24 ± 0.41 2.50 ± 1.13 3.52 ± 0.90
12 0.90 ± 0.04 0.88 ± 0.03 1.03 ± 0.33 1.06 ± 0.44 3.00 ± 1.27 3.65 ± 1.19
Apical
13 0.86 ± 0.02 0.88 ± 0.02 1.39 ± 0.40 1.24 ± 0.43 5.60 ± 1.10 4.20 ± 1.21
14 0.87 ± 0.02 0.89 ± 0.02 1.58 ± 0.42 1.53 ± 0.43 5.16 ± 1.09 4.26 ± 1.32
15 0.88 ± 0.02 0.90 ± 0.02 1.76 ± 0.48 1.56 ± 0.46 5.60 ± 1.11 4.31 ± 0.95
16 0.89 ± 0.03 0.91 ± 0.02 1.83 ± 0.43 1.59 ± 0.40 5.64 ± 1.15 4.71 ± 1.24
Apex 17 0.91 ± 0.03 0.93 ± 0.03 2.00 ± 0.44 1.83 ± 0.45 5.40 ± 1.17 4.81 ± 1.14
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Figure 3: Segmentation accuracy expressed in terms of the DSC, MCD and HD measures.
following two sets of indexes: (1) global indexes
including the LV end-diastolic volume (LVEDV)
and end-systolic volume (LVESV), LV stroke vol-
ume (LVSV), LV ejection fraction (LVEF), LV
myocardial mass (LVM), RV end-diastolic volume
(RVEDV) and end-systolic volume (RVESV), RV
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Figure 4: Examples segmentation results at the ED and ES phases illustrating our three degrees of quality for automated
segmentation contours versus manual contours. Red: automated segmentations. Green: ground-truth segmentations.
Table 5: Categories of segmentation quality for the different approaches presented in this paper.
B (n=600) AS (n=600) AL (n=600) AS (n=4620)
Excellent
MCD <1 pixel
84.19 % 82.14 % 84.21 % 80.67 %
Good
1 pixel <MCD <2 pixels
15.25 % 16.80 % 15.50 % 17.50 %
Bad
MCD >2 pixels
0.55 % 1.05 % 0.30 % 1.82 %
stroke volume (RVSV) and RV ejection fraction
(RVEF); and (2) regional indexes including the my-
ocardium wall thickness, thickening and motion.
Note that we report the clinical indexes obtained
from automated segmentation of subjects that have
successfully passed the IQA and SQA modules. Ta-
ble 6 shows the number of subjects that were in-
cluded in our analysis. For example, of the given
4,620 subjects, 4,430 were deemed of good quality
after IQA and SQA analyses were applied. More
specifically, IQA detected 145 subjects to exclude,
whereas SQA detected 105 subjects to omit; note
that 60 subjects were common to both lists. There-
fore, a total of 190 subjects were automatically re-
moved before continuing with the analysis.
Table 7 shows the main cardiac clinical indexes,
with the two first columns representing the ventric-
ular parameters of the healthy population obtained
through automated and manual segmentations. We
observe here that there was strong agreement be-
tween the two methods for computing the presented
cardiac function indexes (Attar et al., 2018). Simi-
larly, the computed clinical indexes for the large co-
hort of 4,620 subjects correlated well with the corre-
sponding ground-truth values, as shown in columns
three and four of the table; however, we note that
although the mean and standard deviation values
of the RV indexes for the healthy population of 800
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Table 6: A summary of subjects used in our analysis after quality control measures were applied.
Datasets
Total number
of subjects (n)
Detected by
IQA only
Detected by
SQA only
Detected by
IQA & SQA
Remain for
analysis
Healthy population (Petersen et al., 2017) 800 0 21 0 779
All manually segmented 4,620 145 105 60 4,430
Dataset used in (Bai et al., 2018) 600 0 11 0 589
UKB dataset 20,000 284 234 138 19,620
Table 7: Summarising the differences in clinical measures derived from our proposed method and manual segmentation. Here,
GT represents the ground-truth values provided by manual segmentation from Petersen et al. (2017). Values indicate mean ±
standard deviation.
GT Automated GT Automated Automated
(n=800) (n=800) (n=4,620) (n=4,620) (n=20,000)
LVEDV (ml) 144 ± 34 146 ± 31 144 ± 34 144 ± 33 142 ± 26
LVESV (ml) 59 ± 18 60 ± 18 59 ± 20 60 ± 23 53 ± 14
LVSV (ml) 85 ± 20 86 ± 18 84 ± 18 84 ± 19 89 ± 18
LVEF (%) 60 ± 6 60 ± 7 60 ± 6 59 ± 7 63 ± 6
LVM (g) 86 ± 24 87 ± 23 88 ± 23 91 ± 23 92 ± 18
RVEDV (ml) 154 ± 40 154 ± 40 152 ± 37 160 ± 49 165 ± 41
RVESV (ml) 69 ± 24 71 ± 26 67 ± 22 77 ± 26 61 ± 24
RVSV (ml) 85 ± 20 83 ± 21 84 ± 18 82 ± 24 90 ± 27
RVEF (%) 56 ± 6 54 ± 7 57 ± 6 54 ± 11 60 ± 9
subjects were in good agreement, for the population
of 4,620 subjects, the mean and standard deviation
values of the RV indexes differed slightly compared
with the ground-truth values. This correlates with
the larger inter-observer variability shown in Table
3, which is at least in part due to thinness of the RV
myocardium vis-a-vis the LV (Zheng et al., 2018).
Table 8 presents the mean absolute and rela-
tive differences between the automated and manual
measurements, as well as between the automated
and manual measurements computed by different
expert human observers and by the built-in auto-
mated segmentation software of the scanner device
(i.e. inlineVF D13A). We observe here that the ab-
solute and relative differences for two subsets of 50
and 600 subjects matched well and were within the
error range of the three expert human observers.
Similarly, although the range of differences over the
cohort of 4,620 subjects were not directly compa-
rable with a small test set of only 50 subjects, the
difference range still was either within that range
or very close to the difference range obtained by
the different expert observers. Overall, B, AS and
AL performed substantially better than the auto-
mated segmentation obtained from the inlineVF
D13A software; note that these data were retrieved
for every subject from the main UKB database.
Next, in Figure 5, we present Bland-Altman plots
(i.e. the top row of the figure) and correlation plots
(i.e. the bottom row of the figure) of the ventric-
ular parameters computed based on our proposed
automated method and a manual reference cover-
ing 4,620 test subjects. The Bland-Altman plot is
commonly used for analysing agreement and bias
between two measurements. In Figure 5, the Bland-
Altman plots show strong agreement and a mean
difference line at nearly zero, suggesting that the
clinical indexes obtained through the automated
approach have little bias. Conversely, the bias be-
tween different pairs of human observers as reported
by Bai et al. (2018) is considerable – i.e. nearly 8
(ml) for LVEDV and LVESV, approximately 8 (g)
for LVM, and approximately 15 (ml) for RVEDV
and RVESV.
More specifically, Figure 5 presents correlation
plots between the manual and automated methods
for the different cardiac function indexes. The cor-
relation coefficient (corr) measures the strength of
the relationship between two sets of observations.
The strength and direction of the relationship indi-
cates the predictive power of our framework. Co-
efficients for all indexes ranged between 0.85 and
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Table 8: The difference in clinical measures between the automatic and manual segmentations, as well between measurements
by different human observers. M: ground truth provided by manual segmentation (Petersen et al., 2017). VF: Automatic
segmentation obtained from the automatic segmentation software inlineVF D13A. Values indicate mean ± standard deviation.
(a) Absolute difference
O1 vs O2 O2 vs O3 O3 vs O1 B vs M AS vs M B vs M VF vs M AS vs M AL vs M AS vs M
(n=50) (n=50) (n=50) (n=50) (n=50) (n=600) (n=600) (n=600) (n=600) (n=4620)
LVEDV (ml) 6.1 ± 4.4 8.8 ± 4.8 4.8 ± 3.1 4.3 ± 4.9 5.9 ± 4.2 6.1 ± 5.3 12.4 ± 18.5 7.9 ± 9.1 6.5 ± 5.4 9.9 ± 7.5
LVESV (ml) 4.1 ± 4.2 6.7 ± 4.2 7.1 ± 3.8 6.5 ± 5.4 6.8 ± 5.1 5.3 ± 4.9 9.2 ± 14.8 7.0 ± 10.0 5.1 ± 5.0 8.2 ± 6.3
LVM (g) 4.2 ± 3.2 6.6 ± 4.9 6.5 ± 4.8 6.4 ± 3.5 6.0 ± 4.4 6.9 ± 5.5 NA 7.1 ± 6.3 7.0 ± 5.4 9.0 ± 6.7
RVEDV (ml) 11.1 ± 7.2 6.2 ± 4.6 8.7 ± 5.8 8.4 ± 6.8 10.0 ± 5.8 8.5 ± 7.1 NA 10.1 ± 7.2 8.4 ± 7.8 12.9 ± 9.8
RVESV (ml) 15.6 ± 7.8 6.6 ± 5.5 11.7 ± 6.9 13.9 ± 9.9 10.0 ± 6.5 7.2 ± 6.8 NA 8.7 ± 9.5 7.7 ± 6.5 12.2 ± 9.6
(b) Relative difference (%)
O1 vs O2 O2 vs O3 O3 vs O1 B vs M AS vs M B vs M VF vs M AS vs M AL vs M AS vs M
(n=50) (n=50) (n=50) (n=50) (n=50) (n=600) (n=600) (n=600) (n=600) (n=4620)
LVEDV 4.2 ± 3.1 6.3 ± 3.3 3.4 ± 2.2 2.9 ± 3.6 4.2 ± 3.0 4.1 ± 3.5 8.8 ± 12.9 5.0 ± 3.3 4.7 ± 3.3 7.0 ± 5.2
LVESV 6.8 ± 7.5 12.5 ± 8.5 11.7 ± 5.1 12.5 ± 11.2 10.2 ± 8.1 9.5 ± 9.5 17.0 ± 27.7 10.2 ± 9.6 9.3 ± 9.4 12.2 ± 9.6
LVM 4.4 ± 3.3 6.0 ± 3.7 6.7 ± 4.6 8.0 ± 4.8 6.5 ± 4.1 8.3 ± 7.6 NA 8.1 ± 8.2 8.3 ± 7.7 8.2 ± 7.6
RVEDV 8.0 ± 5.0 4.2 ± 3.1 5.7 ± 3.6 5.7 ± 4.3 7.3 ± 4.2 5.6 ± 4.6 NA 6.2 ± 5.0 5.4 ± 4.7 7.8 ± 5.1
RVESV 30.6 ± 15.5 10.9 ± 8.3 16.9 ± 9.2 29.8 ± 22.1 22.0 ± 8.4 11.8 ± 12.2 NA 16.1 ± 9.7 12.4 ± 9.0 19.4 ± 15.0
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Figure 5: Illustrating the repeatability of various cardiac functional indexes comparing the manual and automated analysis of
4,620 subjects from the UKB cohort. The top row shows Bland-Altman plots for various cardiac functional indexes computed
both manually and automatically in which manual segmentation was available. The black horizontal lines denote the mean
difference (i.e. bias), whereas the two red dashed lines denote limits of agreement (LoA) i.e. ±1.96 standard deviations
from the mean. The second row shows correlation plots for various cardiac functional indexes computed both manually and
automatically in which manual segmentation was available.
0.91, indicating a strong relationship between the
manual and automated approaches.
To illustrate whether the values of clinical indexes
computed automatically share the same distribu-
tion as those obtained via the manual approach,
we visualised their distributions. In Figure 6, we
present probability distribution plots (i.e. the top
row of the figure) and Q-Q plots (i.e. the bottom
row of the figure) for various cardiac functional in-
dexes computed both manually and automatically
over the full cohort for which manual segmentations
were available. From the plots, we observe that the
distribution of the various indexes closely match
those obtained from the manual segmentations–
More specifically, we observe a common distribu-
tion, common location and scale, similar distribu-
tional shapes, and similar tail behaviour.
Because ground-truth manual regional (AHA-17)
quantification for the subjects in this study was not
available, all AHA-17 regional indexes reported in
this paper are computed using 3D techniques, in
contrast to the global quantification indexes, where
direct comparison with manual assessment was de-
sirable. Nevertheless, in order to approximate a
comparison with what would be a regional analy-
sis derived from manual delineations, we generated
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Figure 6: Distributions of various cardiac functional indexes comparing results of manual and automatic analyses of 4,620
subjects. The top row shows probability distribution plots, whereas the bottom row shows Q-Q plots for various cardiac
functional indexes computed both manually and automatically in which manual segmentation was available.
3D shapes by non-rigid registration of a model to
all manual delineations. We used the resulting 3D
shapes to perform regional quantification, and com-
pared with our automatic results.
We computed the regional LV myocardial wall
parameters in terms of thickness, thickening, and
motion. Visual results can be seen on Figure 7, and
corresponding numerical results on Table 9. Figure
7 shows the mean and standard deviation values
of the regional analysis of 4,620 subjects for both
the automated and manual approaches in a bulls-
eye display based on the AHA 17-segment model.
We observe here that the (top and bottom) panels
are similar in most regions in terms of the mean
and standard deviation values, thereby confirming
the quality of our fully automated pipeline. Indeed,
results already published in many clinical journals
(Andre et al., 2012; Deviggiano et al., 2016; Punt-
mann et al., 2010; Kanza et al., 2007; Prasad et al.,
2010; Le Ven et al., 2015; Baltabaeva et al., 2007;
Codreanu et al., 2014), primarily based on the man-
ual delineation of a few dozen images confirm the
values and ranges we have obtained and present in
our bulls-eye plots.
Figures 8 and 9 show the distribution of wall
thickness, thickening and motion for all AHA-17
segments in the LV myocardium. These histograms
show measurements obtained from the automated
segmentation applied to two cohorts (i.e. n=4,620
and n=20,000), as well as from manual delineations.
The figures show excellent agreement between mea-
surements obtained from automated segmentations
from both cohorts and those derived from manual
delineations.
We also performed two-sample Kolmogorov-
Smirnov (K-S) tests to verify that ventricular pa-
rameters obtained through manual and automated
approaches are drawn from the same distribution,
under the null hypothesis that the manual and au-
tomatic methods are from the same continuous dis-
tribution in terms of clinical indexes. From our
analysis, K-S test results on different global and re-
gional indexes do not reject the null hypothesis of
being from the same distribution at the 5% signifi-
cance level.
An important final note is that although our im-
age parsing implementation performs fully in 3D,
to ensure a fair comparison with both ground-truth
data and the methods we compare with in this pa-
per, we had to convert our segmentation results to
2D contours from 3D meshes; this does not pose
a problem for objective quantification of segmen-
tation accuracy, however, given the sparse nature
of CMR images, where voxel resolution along the z
axis is typically on the order of 10mm, gross miscal-
culations may occur when approximating volumet-
ric measurements such as ventricular volumes and
myocardial masses via simple integration methods
such as Simpson’s rule. We believe that although
many CNN-based methods have recently received a
15
Wall Thickness (mm)
ED ES
Wall Motion (mm) Wall Thickening (mm)
RV
AHA 17-Segment Model
M
an
ua
l
Au
to
m
at
ed
Wall Thickness (mm) Wall Motion (mm) Wall Thickening (mm)
M
ea
n
SD
ED ES
AHA 17-segments:
1. basal anterior
2. basal anteroseptal
3. basal inferoseptal
4. basal inferior
5. basal inferolateral
6. basal anterolateral
7. mid anterior
8. mid anteroseptal
9. mid inferoseptal
10. mid inferior
11. mid inferolateral
12. mid anterolateral
13. apical anterior
14. apical septal
15. apical inferior
16. apical lateral
17. apex
M
an
ua
l
Au
to
m
at
ed
Figure 7: Segmental LV parameters of 4,620 subjects presented as bulls-eye displays.
lot of attention, showing the capacity for image tex-
ture characterisation, most of them are restricted
to handling 2D data. This simplification can intro-
duce large biases in volume computations, and be
less resilient to image artefacts such as those caused
by breathing motion. In addition to our pipeline ap-
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Table 9: Segmental LV parameters of 4,620 subjects obtained from manual and automatic approaches. Upper rows correspond
to shapes generated from the manual segmentation and lower rows to those obtained with the automatic approach.
ID
Wall Thickness
at ED (mm)
Wall Thickness
at ES (mm)
Wall Motion
(mm)
Wall Thickening
(mm)
12.05 ± 1.84 15.69 ± 1.83 -4.05 ± 4.39 2.95 ± 1.61
1
11.72 ± 1.92 15.59 ± 1.88 -3.46 ± 4.94 2.67 ± 1.66
13.81 ± 1.73 17.49 ± 2.07 -5.70 ± 3.51 2.89 ± 1.74
2
13.59 ± 1.85 17.49 ± 2.14 -4.91 ± 3.97 2.69 ± 1.81
11.63 ± 1.09 13.57 ± 1.26 -8.01 ± 4.28 1.08 ± 1.10
3
11.38 ± 1.20 13.47 ± 1.33 -7.06 ± 4.63 0.87 ± 1.19
9.17 ± 0.97 11.87 ± 1.00 -7.20 ± 5.68 1.76 ± 1.08
4
8.87 ± 1.06 11.65 ± 1.06 -6.20 ± 6.03 1.55 ± 1.18
10.76 ± 1.17 14.00 ± 1.67 -4.60 ± 5.53 2.41 ± 1.86
5
10.45 ± 1.27 13.96 ± 1.77 -3.80 ± 5.96 2.29 ± 1.95
10.02 ± 1.50 13.35 ± 1.81 -4.29 ± 5.21 2.52 ± 1.82
6
9.69 ± 1.58 13.26 ± 1.89 -3.60 ± 5.72 2.35 ± 1.87
8.14 ± 1.46 12.14 ± 1.44 -1.44 ± 5.18 3.15 ± 1.41
7
7.81 ± 1.43 11.96 ± 1.48 -1.31 ± 5.50 2.94 ± 1.42
11.99 ± 1.21 15.03 ± 1.40 -2.33 ± 4.06 2.25 ± 1.18
8
11.68 ± 1.31 14.95 ± 1.46 -1.57 ± 4.40 2.04 ± 1.26
12.63 ± 1.04 14.51 ± 1.32 -2.35 ± 4.37 1.01 ± 1.12
9
12.37 ± 1.15 14.41 ± 1.40 -1.52 ± 4.62 0.84 ± 1.20
9.33 ± 3.59 12.43 ± 1.17 -1.78 ± 5.26 2.25 ± 3.83
10
9.17 ± 4.16 12.28 ± 1.24 -0.93 ± 5.46 1.88 ± 4.23
8.53 ± 3.12 13.09 ± 1.82 -1.02 ± 5.85 3.85 ± 3.49
11
8.25 ± 3.07 13.11 ± 1.91 -0.84 ± 6.11 3.66 ± 3.33
8.17 ± 3.76 13.55 ± 1.94 -1.72 ± 6.23 4.65 ± 4.00
12
7.90 ± 3.14 13.59 ± 2.03 -1.09 ± 6.89 4.50 ± 3.30
7.58 ± 1.45 11.57 ± 1.37 -0.58 ± 5.91 3.10 ± 1.50
13
7.32 ± 1.49 11.40 ± 1.42 -0.39 ± 6.05 2.86 ± 1.56
8.75 ± 1.30 12.40 ± 1.19 1.56 ± 3.91 2.75 ± 1.22
14
8.46 ± 1.33 12.21 ± 1.23 2.32 ± 4.10 2.54 ± 1.28
6.86 ± 3.17 10.89 ± 1.17 2.07 ± 4.59 3.20 ± 3.36
15
6.59 ± 2.02 10.70 ± 1.21 2.93 ± 4.44 2.91 ± 2.09
6.48 ± 4.66 11.58 ± 1.63 0.69 ± 6.22 4.29 ± 4.83
16
6.37 ± 4.44 11.46 ± 1.63 0.41 ± 6.68 3.90 ± 4.49
5.97 ± 4.49 11.17 ± 1.57 1.62 ± 3.21 4.28 ± 5.11
17
5.71 ± 3.63 10.94 ± 4.68 2.58 ± 3.18 4.03 ± 1.68
proach fully supporting 3D data, our method pro-
vides other advantages when compared to 2D CNN-
based implementations. More specifically, the size
of the training dataset required to achieve similar
performance for an equal task differs by at least one
order of magnitude between CNNs and ASM-based
methods. Further, ASM implementations such as
SPASM have the inherent ability to handle multi-
view image volume segmentation without the need
to retrain. This is particularly useful for functional
CMR segmentation in which multiple views of the
heart are captured as part of standard analysis pro-
tocols. In addition, because the output of our seg-
mentation are 3D meshes, more apt mathematical
formulations can be used for volumetric computa-
tion, i.e. Green’s theorem for surface integration,
and any further higher level structural analyses of
the cardiac tissue. Some CNN-based methods such
as those proposed by Zheng et al. (2018) do take
into account inter-dependencies between short-axis
slices potentially resulting in more robust segmen-
tations, even so, such CNN-based algorithms are
still not globally constrained, their output is typ-
ically two dimensional in nature, their training is
very costly both in time and sample size require-
ments, and they cannot handle dynamically chang-
ing input image views without redefinition of the
architecture and re-training. We present the key
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Figure 8: Regional analysis of LV shapes covering 20,000 subjects in terms of distribution of wall thickness at ED and ES
phases. Here, red, blue and green lines indicate ground-truth values for 4,620 subjects, automated values for 4,620 subjects
and automated values for 20,000 subjects, respectively. In all plots, the y-axis represents the relative frequency.
differences between our implementation and the 2D
CNN-based implementation method by Bai et al.
(2018) on Table 10.
3.3. Hardware and Computational Cost
In terms of computational cost of training and
testing, method B takes approximately 10 hours to
train the VGG-16 network on a Nvidia Tesla K80
GPU, and about 11 seconds to segment all 2D slices
of a full cardiac cycle for one subject (Bai et al.,
2018). For our method, it takes approximately 30
minutes to train both the PDM and IAM on a In-
tel Xeon(R) CPU E5-1620 @3.60GHz with 32 GB
of RAM, and about 15 minutes to generate the 3D
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Figure 9: Regional analysis of LV shapes covering 20,000 subjects in terms of distribution of wall motion and thickening. Here,
red, blue and green lines indicate ground-truth values for 4,620 subjects, automated values for 4,620 subjects and automated
values for 20,000 subjects, respectively. In all plots, the y-axis represents the relative frequency.
shapes of a full cardiac cycle for one subject. Fi-
nally, the total end-to-end execution time for the
20,000 subjects using our MULTI-X platform was
performed using 50 Amazon Web Service (AWS)
”m4.10xlarge” machines each with 40 2.4-GHz In-
tel Xeon ES-2676 v3 vCPUs, and 160 GB of RAM.
3.4. Sub-Cohort Analysis
Thus far in this paper we have only shown a
global population analysis of the UKB. We have
presented statistics on the most commonly used
clinical indexes derived from CMR exams. With
the exception of the ”healthy” group as defined by
Petersen et al. (2017), introduced in this paper on
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Table 10: Comparing one of the current state-of-the-art CNN-based methods proposed by Bai et al. (2018) with our proposed
framework.
Bai et al. (2018) Proposed pipeline
Output
  
. . .
2D masks 3D shape
  
. . .
2D masks 3D shape
2D masks 3D surface mesh
Size of training dataset (N)
for equal performance
N ≈ a× 103 N ≈ a× 102
Image slice dimensions
Must match training
(cropping or re-sampling required)
Independent to image size
Image view (SAX, LAX) Must be consistent, i.e. SAX Independent to image view
Slice stack inter-dependency Each slice processed independently Slice stack handled by PDM
Training computational cost High∗ Low∗
Testing computational cost Low∗ High∗
∗For more details see section 3.3.
Table 6, and corresponding quantification results
shown on the first two columns of Table 7, we have
only presented global population statistics. We be-
lieve however that the power of population studies
lies in the opportunity to define and characterise
human sub-populations.
Though in this paper our principal aim is to
present the first fully automatic large-scale, global
and segmental, 3D analysis of this magnitude
we have included some preliminary quantification
results on UKB sub-populations in this section.
Based on the 20,000 subjects available, we have
used patient age at the time of imaging, and patient
gender (male, female), to present cardiovascular in-
dex reference ranges for these cohorts. Table 11
presents the arithmetic mean, and upper/lower
bounds of the 95% prediction interval for each clin-
ical index, and each age group. Each of the three
age-groups span a 10-year interval, and the total
age range includes patients 45 to 74 years old. Also,
for each clinical index, and age-group we compute
separate statistics for males and females.
Figure 10 shows the mean value for each of the
five clinical indexes, for the three different age
groups, and for males and females. Perhaps the
most evident, and in some ways expected feature
of these plots, is the consistent decline in cardiac
volumes and cardiac mass with ageing. For the
five indexes LVEDV, LVESV, LVM, RVEDV and
RVESV, we see a decline of 9%, 15%, 7%, 8%, and
13% for males, and 11%, 17%, 5%, 6%, and 11%
for females. As stated before, a deep analysis of
sub-populations is out of the scope of this paper,
nevertheless, we hope to have shown the potential
of the techniques presented in this paper to gain
insight from large population imaging studies.
4. Conclusions
In this study, we presented a fully automatic
framework capable of performing high-throughput
end-to-end 3D cardiac image analysis of 20,000 sub-
jects. We validated our workflow on a reference co-
hort of 4,620 subjects for which both manual de-
lineations and reference functional indexes exist.
Our results show that differences between our au-
tomatic workflow and the manually obtained global
and regional reference indexes are within the ex-
pected variability observed in human raters. As
future work, we would like to increase the robust-
ness of our pipeline to handle severe pathological
morphology and variable image quality. We fore-
see including feed-back loops in our pipeline that
would allow the automatic adjustment of segmen-
tation parameters for image re-processing, based on
our quality assessment modules. Such feed-back
loops may include triggering of new modules de-
signed to handle poor image quality, or imputation
20
Table 11: Male (M) and Female (F) ventricular reference ranges detailing mean, lower reference limit and upper reference limit
by age group. Reference limits are derived by the upper and lower bounds of the 95% prediction interval for each parameter
at each age group.
Age groups (years) 45-54 55-64 65-74
Number of subjects 3510 7408 8702
Male gender (%) 43% 43% 52%
lower mean upper lower mean upper lower mean upper
M 109 170 231 102 163 223 94 154 213
LVEDV (ml)
F 95 140 184 88 132 175 80 124 168
M 31 81 130 28 75 122 25 69 113
LVESV (ml)
F 25 58 91 21 53 85 15 48 82
M 71 112 152 69 109 148 66 104 142
LVM (g)
F 44 78 111 43 76 108 42 74 107
M 115 197 279 112 191 269 105 182 259
RVEDV (ml)
F 73 145 218 72 141 210 72 136 200
M 38 102 144 34 96 137 31 89 127
RVESV (ml)
F 16 66 116 15 63 110 14 59 105
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Figure 10: Male (blue star marker) and Female (red circle marker) clinical indexes showing their mean value per age group.
of missing data. Similarly, alternative segmentation
techniques could be triggered upon detection of spe-
cific pathologies. Besides increasing the robustness
of our system, we would like to further the analy-
sis of reference ranges for specific sub-populations.
The UKB provides a wealth of patient information
including, socio-demographic, lifestyle and environ-
mental, family history, genetic, and omics data.
Modelling the relationship between these factors
and cardiac morphology and function would help
further our understanding of disease processes, and
potentially increase the specificity of medical treat-
ment.
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